News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
506,167 Results
Type
Article (37189)
Company Profile (148)
Press Release (468830)
Multimedia
Podcasts (71)
Webinars (11)
Section
Business (150130)
Career Advice (1544)
Deals (28911)
Drug Delivery (107)
Drug Development (69722)
Employer Resources (127)
FDA (11829)
Job Trends (11348)
News (267859)
Policy (29464)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (4)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (1960)
Accelerated approval (4)
Adcomms (21)
Allergies (70)
Alliances (46578)
ALS (67)
Alzheimer's disease (1187)
Antibody-drug conjugate (ADC) (106)
Approvals (11820)
Artificial intelligence (194)
Autoimmune disease (19)
Automation (8)
Bankruptcy (277)
Best Places to Work (8852)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (75)
Bladder cancer (49)
Brain cancer (29)
Breast cancer (203)
Cancer (1695)
Cardiovascular disease (141)
Career advice (1300)
Career pathing (22)
CAR-T (109)
Cell therapy (308)
Cervical cancer (16)
Clinical research (56603)
Collaboration (734)
Compensation (441)
Complete response letters (25)
COVID-19 (2534)
CRISPR (36)
C-suite (174)
Cystic fibrosis (69)
Data (1613)
Decentralized trials (1)
Denatured (20)
Depression (37)
Diabetes (228)
Diagnostics (4065)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (35)
Drug discovery (98)
Drug pricing (106)
Drug shortages (31)
Duchenne muscular dystrophy (85)
Earnings (55089)
Editorial (39)
Employer branding (17)
Employer resources (113)
Events (67492)
Executive appointments (510)
FDA (12743)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (525)
Gene editing (84)
Generative AI (15)
Gene therapy (259)
GLP-1 (739)
Government (4306)
Grass and pollen (4)
Guidances (37)
Healthcare (12534)
Huntington's disease (19)
IgA nephropathy (24)
Immunology and inflammation (95)
Indications (24)
Infectious disease (2676)
Inflammatory bowel disease (102)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (81)
Interviews (267)
IPO (12395)
IRA (44)
Job creations (2900)
Job search strategy (1127)
Kidney cancer (7)
Labor market (21)
Layoffs (359)
Leadership (10)
Legal (7839)
Liver cancer (56)
Lung cancer (246)
Lymphoma (118)
Machine learning (5)
Management (39)
Manufacturing (263)
MASH (58)
Medical device (6518)
Medtech (6521)
Mergers & acquisitions (16968)
Metabolic disorders (631)
Multiple sclerosis (55)
NASH (21)
Neurodegenerative disease (74)
Neuropsychiatric disorders (24)
Neuroscience (1612)
NextGen: Class of 2025 (4274)
Non-profit (2981)
Northern California (1807)
Now hiring (10)
Obesity (356)
Opinion (218)
Ovarian cancer (58)
Pain (66)
Pancreatic cancer (65)
Parkinson's disease (122)
Partnered (13)
Patents (192)
Patient recruitment (64)
Peanut (39)
People (40951)
Pharmaceutical (71)
Pharmacy benefit managers (16)
Phase I (16864)
Phase II (24686)
Phase III (19656)
Pipeline (956)
Policy (138)
Postmarket research (2233)
Preclinical (7055)
Press Release (42)
Prostate cancer (83)
Psychedelics (30)
Radiopharmaceuticals (233)
Rare diseases (308)
Real estate (4086)
Recruiting (54)
Regulatory (19191)
Reports (23)
Research institute (1807)
Resumes & cover letters (226)
Rett syndrome (3)
RNA editing (3)
RSV (47)
Schizophrenia (70)
Series A (91)
Series B (44)
Service/supplier (6)
Sickle cell disease (46)
Southern California (1545)
Special edition (9)
Spinal muscular atrophy (147)
Sponsored (19)
Startups (2651)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (27)
The Weekly (49)
United States (15544)
Vaccines (718)
Venture capitalists (29)
Weight loss (266)
Women's health (16)
Worklife (10)
Date
Today (21)
Last 7 days (353)
Last 30 days (1834)
Last 365 days (24840)
2025 (7059)
2024 (26451)
2023 (29743)
2022 (39221)
2021 (42077)
2020 (40254)
2019 (33345)
2018 (25548)
2017 (25253)
2016 (24090)
2015 (27823)
2014 (22008)
2013 (18296)
2012 (19516)
2011 (20307)
2010 (18643)
Location
Africa (693)
Alabama (37)
Alaska (3)
Arizona (121)
Arkansas (7)
Asia (33655)
Australia (5408)
California (4066)
Canada (1522)
China (413)
Colorado (182)
Connecticut (181)
Delaware (106)
Europe (74609)
Florida (646)
Georgia (133)
Hawaii (1)
Idaho (32)
Illinois (366)
India (25)
Indiana (224)
Iowa (6)
Japan (131)
Kansas (76)
Kentucky (16)
Louisiana (9)
Maine (28)
Maryland (704)
Massachusetts (3080)
Michigan (115)
Minnesota (182)
Mississippi (1)
Missouri (56)
Montana (23)
Nebraska (12)
Nevada (39)
New Hampshire (26)
New Jersey (1318)
New Mexico (18)
New York (1214)
North Carolina (684)
North Dakota (4)
Northern California (1807)
Ohio (131)
Oklahoma (7)
Oregon (22)
Pennsylvania (910)
Puerto Rico (10)
Rhode Island (17)
South America (998)
South Carolina (10)
South Dakota (1)
Southern California (1545)
Tennessee (60)
Texas (526)
Utah (95)
Virginia (117)
Washington D.C. (45)
Washington State (348)
West Virginia (2)
Wisconsin (32)
506,167 Results for "santhera pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Santhera shares updates on commercial rollout of AGAMREE®
April 16, 2025
·
4 min read
Press Releases
Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day
March 24, 2025
·
3 min read
Press Releases
Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia
January 16, 2025
·
6 min read
Press Releases
Santhera proposes Dr. Melanie Rolli as new member of Board of Directors
March 27, 2025
·
3 min read
Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
Santhera Pharmaceuticals is pleased to note the launch of AGAMREE® for the treatment of Duchenne muscular dystrophy in the United States by Catalyst Pharmaceuticals, Inc., the Company’s commercialization partner for North America.
March 14, 2024
·
5 min read
Press Releases
Santhera Announces Agreement with German GKV-SV on Reimbursement Amount for AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy in Germany
February 13, 2025
·
5 min read
Press Releases
Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group
January 6, 2025
·
5 min read
Press Releases
Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
January 16, 2025
·
4 min read
Press Releases
Santhera Announces Chief Financial Officer Transition with Appointment of Catherine Isted
February 10, 2025
·
5 min read
Business
Santhera Publishes Annual Report 2023
Santhera Pharmaceuticals announces the publication of its Annual Report 2023 with fully audited results for the year ended December 31, 2023.
May 28, 2024
·
2 min read
1 of 50,617
Next
